propafenone has been researched along with Angina Pectoris in 3 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hopf, R | 1 |
| Becker, HJ | 1 |
| Kober, G | 1 |
| Dowinsky, S | 1 |
| Kaltenbach, M | 1 |
| Dobrotvorskaia, TE | 1 |
| Koroleva, ON | 1 |
| Gordina, OV | 1 |
| Marakanova, AV | 1 |
| Wagner, F | 1 |
| Jähnchen, E | 1 |
| Trenk, D | 1 |
| Eichelbaum, M | 1 |
| Harnasch, P | 1 |
| Hauf, G | 1 |
| Roskamm, H | 1 |
1 review available for propafenone and Angina Pectoris
| Article | Year |
|---|---|
[Treatment of angina pectoris with calcium antagonists].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Therapy, Combination; E | 1982 |
1 trial available for propafenone and Angina Pectoris
| Article | Year |
|---|---|
[Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
Topics: Angina Pectoris; Angina, Unstable; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Di | 1996 |
1 other study available for propafenone and Angina Pectoris
| Article | Year |
|---|---|
Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem, and sparteine.
Topics: Angina Pectoris; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Block | 1987 |